An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation
Clinical trial NCT00403767 · COMPLETED
Trial details
- NCT number
- NCT00403767
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2010-09-01
- Enrollment
- 14269
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.